In collaboration with Instituto de Efectividad Clínica y Sanitaria (IECS) and Tulane University, SPEAC’s Special Populations team has launched a Living Systematic Review focused on the safety, effectiveness,
Over time, the need to revisit and refine public health concepts becomes apparent to ensure they remain accurate and relevant. This process often involves validating these definitions
Lassa virus (LASV), a member of the Arenavirus family, remains a critical public health challenge in West Africa, with the Nigeria CDC reporting a staggering 7767
Lassa fever, a viral disease in West Africa, affects around 2 million people annually, with 5,000–10,000 deaths—but data on its true impact in high-risk groups is limited. Neonates, children, and pregnant
Last week, Safety Platform for Emergency vACcines (SPEAC) and CEPI (Coalition for Epidemic Preparedness Innovations) members participated in the 23rd annual conference of the International
The SPEAC Project updated its initial list of adverse events of special interest for mpox on 17 September. Version 1.0 is now available here. SPEAC
The Safety Platform for Emergency vACcines (SPEAC) is a project funded by the Coalition for Epidemic Preparedness Innovations (CEPI). SPEAC is located at Brighton Collaboration, a program of the Task Force for Global Health.
© SPEAC 2023. All rights reserved.
